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Background: We previously reported that the peripheral regulatory T cells (pTregs) generated ‘on-demand’ in the
retina were crucial to retinal immune privilege, and in vitro analysis of retinal dendritic cells (DC) showed they
possessed antigen presenting cell (APC) activity that promoted development of the Tregs and effector T cells
(Teffs). Here, we expanded these findings by examining whether locally generated, locally acting pTregs were
protective against spontaneous autoimmunity and autoimmunity mediated by interphotoreceptor retinoid-binding
protein (IRBP). We also examined the APC capacity of retinal DC in vivo.
Methods: Transgenic (Tg) mice expressing diphtheria toxin receptor (DTR) and/or green fluorescent protein (GFP)
under control of the endogenous FoxP3 promoter (GFP only in FG mice, GFP and DTR in FDG mice) or the CD11c
promoter (GFP and DTR in CDG mice) were used in conjunction with Tg mice expressing beta-galactosidase (βgal)
as retinal neo-self antigen and βgal-specific TCR Tg mice (BG2). Retinal T cell responses were assayed by flow
cytometry and retinal autoimmune disease assessed by histological examination.
Results: Local depletion of the Tregs enhanced actively induced experimental autoimmune uveoretinitis to the
highly expressed retinal self-antigen IRBP in FDG mice and spontaneous autoimmunity in βgal-FDG-BG2 mice, but
not in mice lacking autoreactive T cells or their target antigen in the retina. The presence of retinal βgal downregulated
the generation of antigen-specific Teffs and pTregs within the retina in response to local βgal challenge. Retinal DC
depletion prevented generation of Tregs and Teffs within retina after βgal injection. Microglia remaining after DC
depletion did not make up for loss of DC-dependent antigen presentation.
Conclusions: Our results suggest that local retinal Tregs protect against spontaneous organ-specific autoimmunity and
that T cell responses within the retina require the presence of local DC.
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While various types of T cells possess regulatory activity
[1,2], it is well established in mice that CD4+CD25+
FoxP3+ T cells are a dominant regulatory T cell (Treg)
and indispensible for immune homeostasis [3,4]. FoxP3+
Tregs are broadly categorized by their origin as either
thymically-derived Tregs (tTregs) or as peripherally-
derived Tregs (pTregs) [5]. Most FoxP3+ Tregs are
tTregs. Their generation, along with negative selection* Correspondence: mcphe003@umn.edu
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article, unless otherwise stated.of strongly autoreactive T cells in the thymus, provides a
foundation against autoimmunity. pTregs are thought to
assist tTregs in limiting autoimmune inflammation [6].
In addition, pTregs are important in regulating immune
responses to external antigens (Ag) encountered in the
gut or airway, providing maternal-fetal tolerance [7-9],
as well as tolerance to commensal microbiota [10-12].
Analysis of pTregs for their overall contribution to the
Treg population, as well as their exact sites of generation
and action (within a specific tissue or nearby secondary
lymphoid tissue), is a matter of ongoing investigation.
Limiting these studies is the lack of unique marker(s) dis-
tinguishing tTregs and pTregs. Some reports suggestedtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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specifically marked tTregs. Other studies argued that
Helios was upregulated in pTregs and activated T cells
[15,16] and was not expressed in all tTregs [17]. Likewise,
neuropilin-1 might not be a definitive Treg subset marker
as pTregs expressed it during inflammation [18], and its
expression was influenced by the local cytokine milieu,
particularly TGF-β [19], a factor known to be critical for
pTreg development. Nonetheless, it is well established that
Tregs are generated in secondary lymphoid tissue as a re-
sult of interaction between Ag-bearing dendritic cells
(DC) and T cells, and exert their regulatory action by lim-
iting the priming of T cells [20]. Tregs are also known to
reside and accumulate in non-lymphoid tissue, especially
in response to inflammation. However, it has been difficult
to determine if these tissue Tregs resulted from immigra-
tion of tTreg or were pTregs generated in secondary
lymphoid tissue.
The accumulation of Tregs in non-lymphoid tissues
also allows for the possibility that they might be gener-
ated directly within the tissue from naïve or effector T
cells (Teffs). A recent study showed pTreg development
dependent on resident lung macrophages [21]. Although
the macrophages were isolated, Ag-pulsed, and then
reintroduced in recipient mice by intra-tracheal transfer
along with FoxP3− T cells, the resulting pTregs and mac-
rophages were primarily found in lung tissue and not in
the mediastinal lymph nodes. The retina, because of its
apparent lack of lymphatic drainage [22] and high con-
centration of TGF-β [23] and retinoic acid [24], might
also be a site for tissue-specific pTreg generation. In-
deed, injection of naïve T cells specific for the retinal Ag
interphotoreceptor retinoid binding protein (IRBP) into
the posterior segment of the eye resulted in their conver-
sion to FoxP3+ Tregs [25]. Subsequently, we expanded
on this result demonstrating that FoxP3+ Tregs specific
for retinal Ag were generated within the retina from cir-
culating Ag-specific FoxP3− T cells [26]. Further, these
pTregs provided a local, specific protection against ex-
perimental autoimmune uveoretinitis (EAU) induced by
Ag immunization or adoptive transfer of activated, ret-
inal Ag-specific T cells.
Given that central tolerance (negative selection and
tTreg generation) to self-Ags is not always complete
[27], our results implied that local, ‘on demand’ gener-
ation and action of pTregs for tissue specific self-Ags
provided a crucial secondary mechanism for immune
homeostasis that functioned in immune privileged tis-
sues. Critical to the development and activation of
pTregs is interaction with appropriate antigen presenting
cells (APC). Microglia (MG) have long been considered
to be the primary APC of CNS tissue [28-33]. In quies-
cent CNS, particularly the retina, there is controversy
about the existence, function, and significance of DC asAPC [34-37]. However, there is a growing body of evi-
dence for DC in the CNS [38]. We recently demonstrated
the presence of DC in quiescent retina, their expansion in
response to neural injury, and their capability as APC
in vitro to generate Teffs and Tregs [39,40].
In this study, we investigated the role of locally gener-
ated, locally acting pTregs in immune homeostasis and
the ability of retinal DC to support T cell activation and
expansion within the retina. Using mice that express E.
coli beta-galactosidase (βgal mice) as a retinal neo-self
Ag along with CD4+ T cell receptor transgenic (TCR-Tg)
mice specific for βgal, and mice with selectively deplet-
able Tregs or DC, we found that local depletion of Tregs
from the retina was sufficient to permit development of
spontaneous EAU and that local DC, not MG, were ne-
cessary to generate Ag-specific T cell responses within
the retina that included pTreg generation.
Materials and methods
Mice
The βgal mice (B6-arrβgal mice, MHC haplotype I-Ab or
B10.A-arrβgal, MHC haplotype I-Ak) have been described
in detail elsewhere [26,41-43]. Briefly, rod photoreceptor
cell expression of βgal mimics that of endogenous arrestin,
producing approximately 150 ng βgal/retina and < 0.5 ng
βgal/pineal gland. Analysis of tissue for βgal expression
was done as described [43] with the following modifica-
tions: the 12 μM cryostat sections of OCT-embedded
tissue were fixed in PBS with 4% paraformaldehyde
and 0.25% gluteraldehyde for 7 min and then incubated
with X-gal substrate (5-bromo-4-chloro-3-indolyl β-D-
galactoside) for 2 to 24 h. The βgalTCR mice (B10.A) and
the BG2 mice (C57BL/6 J) mice carry MHC class II
restricted (CD4+) T cells that recognize βgal protein, spe-
cifically epitopes YVVDEANIETHGMV (βgalTCR) or
SVTLPAASHAI (BG2), and have been described else-
where [44,45]. The FG mice, which express green fluores-
cent protein (GFP) only under control of the endogenous
FoxP3 promoter, and FDG mice, which express diphtheria
toxin receptor (DTR) and GFP under control of the en-
dogenous FoxP3 promoter, have been described [4,46];
both are C57BL/6 J. The CDG mice (C57BL/6 J) express a
chimeric GFP and DTR under control of a transgenic
CD11c promoter [47]. Rag−/− mice (RAG-2−/− mice, stock
# 008449) were obtained from breeding stock purchased
from Jackson Laboratory (Bar Harbor, ME, USA). All mice
were negative for the rd8 mutation associated with retinal
degeneration [48]. All mice were handled in accordance
with the Association for Research in Vision and Ophthal-
mology (ARVO) Statement for the Use of Animals in
Ophthalmic and Vision Research, and the University of
Minnesota Institutional Animal Care and Use Committee
guidelines. Mice were housed under specific pathogen-free
conditions on lactose-free chow.
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For induction of pTregs in response to soluble Ag, FG
mice were injected intravenously (i.v.) with 100 μg of
βgal or bovine serum albumin (BSA) solubilized in
phosphate buffered saline (PBS) at 1 mg/mL. At 8 days
post-injection, CD4+ T cells were isolated from pooled
lymph nodes (LN) and spleens by magnetic separation
(Miltenyi, San Diego, CA, USA) and then sorted by
fluorescence-activated cell sorting (FACS) for GFP+
(FoxP3+ Tregs) cells. The cells were washed and resus-
pended in PBS to 5 × 106/mL. For induction of pTregs
in response to retinal βgal, magnetically purified CD4+ T
cells from normal FG-BG2 double transgenic mice were
sorted by FACS for GFP− cells. The cells were washed
and resuspended to 5 × 105/mL. Cells were transferred
i.v. with recipient mice and number of cells transferred
indicated.Injections
Diphtheria toxin (DTx), βgal, and saline injections into
the eye were done by trans-corneal deposition into the
anterior chamber (AC) as previously described [40]. One
microliter doses containing saline or the indicated amount
of DTx or βgal were given. Systemic depletion of Tregs or
DC was done by intraperitoneal (i.p.) injections of DTx
with dose and timing indicated.Analysis of the delayed-type hypersensitive response and
enucleations
Analysis of the delayed-type hypersensitive (DTH) re-
sponse (ear swelling assay) was done by injection of
βgal (50 μg in 10 μL) into the ear pinna as previously
described [49]. Enucleations were done as previously de-
scribed [50].Induction and analysis of autoimmune disease
EAU was induced by subcutaneous (s.c.) immunization
of mice with a single 200-μL dose containing a total of
200 μg of mouse IRBP peptides 1 to 20 (kindly provided
in part by Dr. R. Caspi) and 461 to 480 (100 μg
each peptide) emulsified in complete Freund’s adjuvant
(CFA) containing 5 mg/mL Mycobacterium tuberculosis
(H37Ra, Sigma, St. Louis, MO, USA) followed by 0.5 μg
pertussis toxin (Sigma) per mouse given in 100 μL saline
i.p. At 21 days post-immunization, the eyes were har-
vested, fixed in 10% buffered formalin, paraffin embed-
ded, sectioned (5 μM), and stained with hematoxylin
and eosin. The slides were examined in a masked fash-
ion and the induced EAU was scored from 0 (no disease)
to 5 (complete loss of photoreceptor cells plus damage
to the inner layers of the retina) based on histopatho-
logical changes in the retina [51].Flow cytometry
Pooled spleen and LN cell suspensions from the indi-
cated mice were prepared by tissue homogenization
followed by filtration through a 70 μM cell strainer.
Lymphocytes were also prepared from whole blood. Red
blood cells were lysed using 0.17 M NH4Cl, and the
remaining cells were washed twice in PBS with the final
suspension made in FACS buffer (PBS with 2% FCS and
0.02% sodium azide). 0.25 to 2.0 μL/106 cells of the ap-
propriate fluorescent-labeled antibodies (BD Biosciences,
San Jose, CA, USA or eBioscience, San Diego, CA, USA)
were added to the cell suspension and incubated on ice
for 30 min. The cells were washed, resuspended in FACS
buffer, and analyzed on FACSCalibur or FACSCanto flow
cytometers using CellQuest (BD Biosciences) or FlowJo
(Tree Star, Ashland, OR, USA) software. CD4+ T cells
from immunized FG mice and normal BG2 x FG mice
were sorted into regulatory (GFP+) or effector (GFP−)
populations using a FACSAria flow cytometer (BD Bio-
science). For analysis of retinal cells by flow cytometry,
mice were euthanized, perfused, and the retinas removed
as described [40]. Control experiments showed that the
perfusion procedure effectively removed passenger cells
from the retinal vasculature so that their contribution
was not significant (data not shown). The retinas were
dissociated using a solution of 0.2 μg/mL Liberase/TM
(Roche, Indianapolis, IN, USA) and 0.05% DNase in
PBS, and stained with the indicated antibodies. Gating
strategy and analysis of retinal mononuclear cells and
lymphocytes has been described [26,40]. For the purpose
of analysis, a single sample comprised all cells collected
from a single retina.
Results
Beta-galactosidase (βgal)-specific regulatory T cells are
made in the periphery and modulate CD4+ T cell
responses to βgal
The lack of βgal expression in the thymus of βgal mice
by reverse transcription PCR (RT-PCR) [50] and X-gal
staining (Figure 1A) suggested that most βgal-specific
Tregs are likely pTregs. This was supported by our stud-
ies that showed that injection of Ag into the naïve
mouse eye led to local generation of pTregs that inhib-
ited EAU [26]. In further support, we sought additional
direct evidence for the peripheral generation of βgal-
specific Tregs, evidence for their function both in the
retina and systemically, and evidence that the presence
of the retina affected the generation of circulating
pTregs.
To demonstrate that functional, βgal-specific, FoxP3+
pTregs could be generated in vivo, we asked if Tregs in-
duced by administration of soluble Ag [52] and then
transferred into BG2 mice could suppress the DTH re-
sponse of βgal-specific CD4+ BG2 T cells. FG mice were
Figure 1 Regulatory T cells (Tregs) specific for beta-galactosidase
(βgal) were generated in the periphery and modulated a CD4+ T
cell mediated delayed-type hypersensitivity (DTH) response. (A)
X-gal staining of retina and thymus from a βgal mouse and control
B6 mouse thymus. Photoreceptor (PC) layer of βgal mouse retina
indicated showing intense X-gal staining in the outer plexiform layer
(top) and outer segments (bottom). Retinas were incubated for 2 h and
thymus for 24 h with X-gal. (B) Inhibition of CD4+ T cell (BG2)-induced
DTH to βgal in mice receiving βgal specific Tregs. Transferred mice
received 5 x 105 Tregs intravenously (i.v.) from mice injected with
bovine serum albumin (BSA) or βgal. Recipient mice were given βgal in
the ear and then measured for ear swelling at the indicated times
post-βgal injection. (C) Percent of pooled CD4+ T cells that are Tregs
(GFP+) in control and antigen (Ag)-inoculated FG mice. (D) Enhancement
of BG2-induced DTH following systemic depletion of Tregs. Mice were
depleted by 250 ng DTx given intraperitoneally (i.p.) on days 0, 3, and 6,
followed by βgal in the ear on day 7. Ear swelling was measured at
indicated times post-βgal injection. (E) Analysis of Treg levels in the
blood of control mice and FDG-BG2 mice given DTx i.p. at the time of
βgal injection in the ear (day 7). Results are given as mean ± SD with
P values determined by t test.
McPherson et al. Journal of Neuroinflammation 2014, 11:205 Page 4 of 14
http://www.jneuroinflammation.com/content/11/1/205injected i.v. with βgal or BSA. After 8 days, GFP+ Tregs
from the βgal and BSA treated mice were purified by
FACS and transferred into separate groups of naïve BG2
mice. The recipient BG2 mice were then analyzed for
their DTH response to βgal. Control BG2 mice had a
significant DTH response to βgal compared to naïve B6
mice (Figure 1B). After transfer, BG2 mice that received
Tregs from BSA treated mice had no reduction in ear
swelling compared to control mice, while mice receiving
Tregs from βgal treated mice showed a significant re-
duction in ear swelling (Figure 1B). FACS analysis
showed that the size of the overall Treg population
measured as a percent of circulating CD4+ T cells was
unaffected by Ag injection (Figure 1C), a finding not un-
expected given that homeostatic mechanisms tightly
regulate the overall size of the T cell pool and its subsets,
including Tregs [53-56]. However, the results indicated
that Ag-specific, βgal-induced pTregs were generated in
sufficient numbers to have a significant effect on the
DTH response of βgal-specific CD4+ BG2 T cells. Con-
versely, we also examined whether removal of Tregs would
enhance the DTH response to βgal. FDG-BG2 double Tg
mice were depleted of Tregs by systemic injections of DTx
and then assayed for their DTH response to βgal. Treg
depleted FDG-BG2 mice had significantly increased ear
swelling compared to control FDG-BG2 mice (Figure 1D,
top). To show that the increase ear swelling was specifically
due to Treg depletion, we also compared the DTH re-
sponse in DTx and non-DTx treated BG2 mice (Figure 1D,
bottom) and found it was similar to each other and to the
undepleted FDG-BG2 mice. Analysis of blood for circulat-
ing Tregs showed that DTx treated FDG-BG2 mice
were substantially depleted of Tregs compared to control
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periments do not carry the βgal transgene, the results show
a detectable level of control of the BG2-mediated DTH re-
sponse by spontaneously generated Tregs, and that addition
(Figure 1B) or depletion (Figure 1D) of even a small num-
ber of circulating, βgal-specific Tregs can modulate the im-
mune response to βgal in a site not thought to be immune
privileged.
Since greater than 99.8% of the βgal in βgal mice is
expressed in the retina, a comparison of mice with or
without the principal βgal source removed by enucle-
ation would test the role of the retinal Ag in βgal-
specific pTreg development. Mature, naïve CD4+ T cells
from FG-BG2 double Tg mice were sorted by flow cytom-
etry for GFP− (FoxP3−) cells and transferred into normal
or enucleated B6-βgal x Rag−/− mice. Since Rag−/− mice
lack T cells, including endogenous Tregs, all new Tregs
must be pTregs derived from the transferred FoxP3− T
cells. When challenged with Ag to determine specificity,
recipient mice totally lacking βgal (Rag−/− mice) or lacking
retinal βgal (enucleated B6-βgal x Rag−/− mice) had an
equivalent elevated DTH response compared to βgal+ re-
cipients (Figure 2A), suggesting that the retinal βgal pro-
motes the generation of functional retinal Ag-specific
pTregs from naïve, mature precursor T cells in the periph-
ery. To assess the stability of retina-dependent pTregs,
DTH responses were also analyzed in B10.A-βgal x Rag−/−
mice where precursor T cells were provided in the mice by
their also having a βgalTCR transgene. At 4 months post-
enucleation, we observed similar levels of DTH inhibition
in both normal and enucleated βgalTCR x B10.A-βgal x
Rag−/− mice compared to similarly treated βgalTCR x
Rag−/− mice (Figure 2B). Together, these results show
retinal βgal was the primary Ag source for βgal-specific
pTreg formation and that once formed, functional βgal-
specific Tregs persisted in circulation even if the source of
Ag was removed.
Local regulatory T cell depletion from the retina induces
spontaneous experimental autoimmune uveoretinitis
B6 mice are minimally permissive for experimental auto-
immune uveoretinitis (EAU) [57,58]. Recently, we dem-
onstrated that cells expressing DTR could be locally
eliminated from the retina by AC injections of DTx
[39,40] and that depletion of retinal Tregs in B6-βgal
mice enhanced βgal-mediated EAU induced by adoptive
transfer or immunization [26]. To confirm the import-
ance of local Tregs within the retina, we sought evidence
that they were also protective against spontaneous auto-
immunity. Control B6 mice and strains expressing DTR
in FoxP3+ cells were given various regimens of DTx into
the right AC and analyzed after 3 weeks of treatments
(Figure 3A). Control B6 mice given AC DTx did not ex-
hibit any signs of retinal autoimmunity. FDG and βgal-FDG mice each exhibited a rare incident of retinal auto-
immune disease (1/71 and 1/77, respectively) following
AC depletion of Tregs (Figure 3A). Given that FDG and
βgal-FDG mice highly express a number of known, en-
dogenous, immunopathogenic, retinal auto-antigens (for
example, IRBP, opsin, arrestin, and recoverin), but do not
have an elevated frequency of one particular retinal-Ag
specific Teff population, the resulting T cell-mediated
autoimmunity could be directed against any of several ret-
inal self-Ags. As expected, FDG-BG2 mice did not develop
retinal autoimmunity, as their Teffs are largely βgal-
specific thus having only a limited repertoire against self-
Ags [26]. However, mice having a high frequency of Teffs
specific for βgal plus cognate βgal Ag expression in the
retina (βgal-FDG-BG2 mice) did develop EAU at a signifi-
cant rate (15/82, 18.3%) following retinal Treg depletion,
with a general trend of increased incidence with higher
DTx doses (Figure 3A). The left eyes of most of the
βgal-FDG-BG2 mice were also examined and found to be
negative for EAU (0/74, data not shown). Further, βgal-
FDG-BG2 mice that were given AC saline injections did
not develop retinal autoimmunity in that eye (0/22,
Figure 3A, bottom). The lack of disease in the left eyes of
DTx treated mice and in the saline injected eyes demon-
strates that the autoimmunity in DTx treated eyes was
specifically due to the local depletion of Tregs from the
retina and that Tregs need to be present within the retina
to be protective. Analysis of circulating Tregs showed no
difference between naïve and AC DTx treated βgal-FDG-
BG2 mice (Figure 3C), again supporting the idea that
circulating Tregs play a secondary role in protection of
the retina from autoimmunity relative to the contribution
of local Tregs.
Prolonged, systemic regulatory T cell depletion in
βgal-FDG-BG2 mice induces spontaneous experimental
autoimmune uveoretinitis
Although DTx given systemically can penetrate the ret-
ina and deplete DTR+ cells from the retina [40], it was
of interest to observe in our previous studies [26] that
EAU induced by βgal immunization or adoptive transfer
of activated, βgal-specific T cells could not be enhanced
by systemic DTx treatment. Since immunization and
adoptive transfer protocols result in only a brief window
for a limited number of activated T cells to elicit EAU,
we hypothesized that systemic DTx treatment of βgal-
FDG-BG2 mice might generate EAU at a high rate since
the retinas in these mice would be exposed to a very
high number of Ag-specific Teffs, as depletion of Tregs
would lead to polyclonal T cell activation. The highest
dose of AC DTx (25 ng, 3x per week, 3 weeks) when
delivered systemically (systemic low dose) did not alter cir-
culating Treg levels compared to naïve mice (Figure 4A)
and failed to induce EAU (0/40, Figure 4B), again
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immunity. While it is known that systemic Treg depletion
results in polyclonal activation of autoreactive T cells lead-
ing to progressive multi-organ autoimmune disease [4], a
high dose of systemic DTx that resulted in near total TregFigure 2 New, peripherally generated beta-galactosidase (βgal)-speci
(DTH). (A) Ear swelling assay showing that retinal βgal is required to gene
Mice were analyzed 80 days post-transfer of 5 x 104 CD4+GFP− cells from F
retina is not necessary for maintaining βgal-specific Tregs. Mice were enucleat
Ear swelling measured at indicated time post-βgal injection. Results are givendepletion (Figure 4A) only induced EAU in βgal-FDG-
BG2 mice at a rate similar to the local depletion (4/22,
18.2%, Figure 4B), and not at all in the other strains lack-
ing the combination of βgal-specific TCR-Tg T cells, ret-
inal βgal, and DTx-depletable Tregs (Figure 4B).fic regulatory T cells (Tregs) inhibit delayed-type hypersensitivity
rate βgal-specific Tregs that can modulate the DTH response to βgal.
G-BG2 mice. (B) Ear swelling assay showing that the presence of the
ed and compared to non-enucleated mice 4 months post-enucleation.
as mean ± SD with P values determined by t test.
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responses
Small numbers of DC in the quiescent retina can be
identified by GFP expression in CDG mice and in vitro
these retinal DC act as APC [39,40]. To assess whether
retinal DC function as APC locally within the retina,
we crossed FG-BG2 mice with DC-depletable CDG
mice (FG-BG2-CDG mice). While large doses of DTx
(200 ng) are highly effective in short-term assays [59],
they are eventually lethal to CDG mice. We found that
GFP+ DC can be depleted from the retina by serial i.p.
administration of small doses of DTx (25 ng) for up to
10 days [40]. This, combined with our other finding that
AC injection of βgal induces a T cell response within the
retina of FG-BG2 mice [26] provided a way to examine
the role of retinal DC in the retinal T cell response
(Figure 5A). Although in FG-BG2-CDG mice both Tregs
and DC are GFP+, we distinguished the cells by CD4
and CD11b staining. βgal-specific BG2 T cells are also
positive for TCR-Vα11.Figure 3 Local depletion of regulatory T cells (Tregs) induces spontaneo
autoimmune uveoretinitis (EAU) in the eyes of mice following anterior chamb
timing, and duration of AC injection protocols are indicated. Statistical set A c
determined by Fisher’s exact test. Statistical set B compares mice with or with
exact test. (B) Representative histology of eyes from βgal-FDG-BG2 mice that
sorting (FACS) analysis of peripheral blood mononuclear cells showing AC inje
mean ± SD with P values determined by t test.Injection of βgal into the AC of FG-BG2-CDG mice
stimulated a retinal T cell response that included BG2
(Vα11+) and nonspecific Teffs (Vα11−), as well as Tregs
that were BG2 or nonspecific (Figure 5B). In contrast,
non-TCR-Tg (BG2−) controls (FG mice) did not have a
significant T cell response when given AC injections of
βgal (Figure 5B), suggesting that the response of Ag
nonspecific Vα11− T cells within the retina of BG2
mice is dependent on generating the βgal-specific
Vα11+ T cell response that produces cytokines and
chemokines that can support the recruitment of Ag
nonspecific T cells into the retina. If FG-BG2-CDG
mice were also treated with DTx to deplete DC, the
entire T cell response (Teff and Treg, BG2 and non-
specific) to βgal was eliminated, yielding T cells num-
bers similar to naïve FG-BG2-CDG mice and FG-BG2
mice given AC saline (Figure 5B). When given βgal
and DTx, control FG-BG2 mice lacking depletable DC
had a similar T cell response to βgal stimulated FG-
BG2-CDG mice.us autoimmune disease. (A) Incidence and severity of experimental
er of the eye (AC) injections of diphtheria toxin (DTx) or saline. Amount,
ompares βgal-FDG-BG2 mice treated with saline or DTx, P values
out BG2 T cells following DTx treatment, P values determined by Fisher’s
received DTx or saline into the right AC. (C) Fluorescence-activated cell
ction of DTx does not alter circulating Treg levels. Results are given as
Figure 5 Depletion of retinal dendritic cell (DC) eliminates the
local immune response. (A) Schematic showing timing and
location of diphtheria toxin (DTx) (25 ng), beta-galactosidase (βgal)
(10 μg), and saline injections. (B) Fluorescence-activated cell sorting
(FACS) analysis showing reduction in T cell numbers in retinas
depleted of DC. T cells were analyzed as being effector (GFP−) or
regulatory (GFP+) and βgal-specific (Vα11+) or nonspecific (Vα11−).
(C) FACS analysis of retinal mononuclear cells showing that DC but
not microglia (MG) were reduced in mice treated with DTx. Results
are given as mean ± SD with P values determined by t test.
Figure 4 Systemic depletion of regulatory T cell (Tregs) induces
spontaneous autoimmune disease in the retina. (A) Analysis of
circulating Tregs levels following low and high dose systemic
depletion protocols. Results are given as mean ± SD with P values
determined by t test. (B) Incidence and severity of experimental
autoimmune uveoretinitis (EAU) following systemic injections of
diphtheria toxin (DTx). Amount, timing, and duration of systemic
DTx injection protocols are indicated. P values determined by
Fisher’s exact test. Analysis of EAU and Treg levels were done at
21 days post-initial DTx injection.
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(CD11b+ cells, but not Ly6G+ polymorphonuclear granu-
locytes). FG-BG2-CDG mice given AC βgal had an ele-
vated number of DC (CD11b+GFP+ cells) compared to
naïve controls, but MG numbers were similar (Figure 5C).
However, when these mice were also given DTx, DC num-
bers were reduced to background while MG numbers
were unchanged. Total mononuclear cell numbers in βgal/
DTx treated control FG-BG2 mice lacking GFP-labeled,
depletable DC were similar to βgal treated FG-BG2-CDG
mice (Figure 5C). Together, this data suggested that there
is a DC-dependency in the retinal Teff and Treg responses
to specific Ag, and that neither MG nor GFP− recruited
macrophages contributed to the T cell response.
Beta-galactosidase in the retina primes it toward
immunological unresponsiveness
Previously, we established that there is a robust T cell re-
sponse in the retinas of FDG-BG2 mice to locally
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did not affect the Ag-stimulated appearance of Tregs
within the retina, leading to our conclusion that protect-
ive Tregs were made ‘on-demand’ [26]. Given that T cell
responses within the retina are dependent on local DC
and that DC from quiescent retina favor Treg produc-
tion [39], we assessed whether the T cell response within
the retina would be limited in mice expressing retinal
βgal. To ascertain the effect of retinal βgal on the im-
mune response to exogenous Ag, we compared the T
cell response in FDG-BG2 and βgal-FDG-BG2 mice fol-
lowing AC injection of βgal with or without systemic
pre-depletion of Tregs (Figure 6A). In agreement with
our prior findings [26], retinal Teffs (GFP−Vα11+ and
GFP−Vα11− cells) increased following AC βgal injection
in FDG-BG2 mice, especially with systemic Treg deple-
tion (Figure 6B, D-left side of panels). AC injection of
βgal into FDG-BG2 mice also increased retinal Treg
numbers (GFP+Vα11+ and GFP+Vα11− cells) regardless
of whether they were systemically pre-depleted by treat-
ment with DTx (Figure 6C, E-left side of panels). InFigure 6 Retinal beta-galactosidase (βgal) expression induced immun
experiments. Mice received 250 ng diphtheria toxin (DTx) and/or βgal (20 μ
fluorescence-activated cell sorting (FACS) 3 days post-injection to the anter
were analyzed as being effector (GFP−) or regulatory (GFP+) and βgal-speci
P values determined by t test comparing FDG-BG2 to βgal-FDG-BG2 mice fcontrast, AC βgal injection done in mice expressing ret-
inal βgal resulted in a significantly reduced number of
GFP− and GFP+ Vα11+ T cells (Figure 6B, C-right side
compared to left side of panels for βgal) showing that
both the Teff and Treg Ag-specific response to βgal was
limited. The downregulation of the response was not
due to elevated Vα11+ Tregs associated with retinal βgal
expression as Ag-specific Teffs and Tregs were also re-
duced between FDG-BG2 and βgal-FDG-BG2 mice fol-
lowing systemic DTx plus AC βgal (Figure 6B, C-right
side compared to left side of panels for βgal/DTx). Ret-
inal βgal expression also reduced the Vα11− T cell re-
sponse to AC βgal injection (Figure 6D, E-right side
compared to left side of panels for βgal). However, the
number of Vα11− Tregs and Teffs was similar between
βgal-FDG-BG2 and FDG-BG2 mice following systemic
DTx plus AC βgal (Figure 6D, E-right side compared to
left side of panels for βgal/DTx), likely the result of
expansion of polyclonal, self-reactive Vα11− T cells no lon-
ger under the control of circulating Tregs due to their de-
pletion. These results suggest that βgal expression withinological unresponsiveness. (A) Legend and time course of the
g) or saline as indicated. Retinal T cell analysis was done by
ior chamber of the eye (AC). (B-E) Number of T cells per retina. T cells
fic (Vα11+) or nonspecific (Vα11−). Results are given as mean ± SD with
or each type of T cell with significant differences indicated by bracket.
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ive environment.
Local depletion of regulatory T cell enhances
interphotoreceptor retinoid binding protein-induced
experimental autoimmune uveoretinitis
B6 mice are minimally permissive for EAU [57,58]. Re-
cently, we demonstrated that cells expressing DTR could
be locally eliminated from the retina by AC injections of
DTx [39,40], and that depletion of retinal Tregs in B6-
βgal mice enhanced βgal-mediated EAU [26]. To assess
whether our findings extended to an endogenous retinal
Ag, we asked if retinal depletion of Tregs could also en-
hance EAU induced by IRBP, an extracellular retinal pro-
tein with a much greater expression level then βgal, and
the most common retinal self-Ag used to induce EAU in
mice [58]. FDG mice were immunized with peptides of
IRBP, with or without injection of DTx into the right
AC. Immunized only mice, as well as the left eyes of im-
munized mice that received AC injections of DTx, devel-
oped a similarly modest incidence and severity of EAU
(Figure 7A, B). However, Treg-depleted retinas from
right eyes had a significant enhancement in the inci-
dence and severity of EAU. Analysis of blood showed
that the AC injections of DTx did not lower circulating
Treg levels but actually resulted in a slight increase overFigure 7 Interphotoreceptor retinoid binding protein (IRBP)-induced
regulatory T cells (Tregs). (A) Incidence and severity of experimental auto
right and left eyes of FDG mice that were IRBP-immunized and given diph
were given 25 ng of DTx 3 times per week for 3 weeks starting the day of im
(B) Histology of right and left eyes from IRBP-immunized mice given DTx into
DTx-treated FDG mice (day 21). For disease scores, mean and SD are gi
and Mann–Whitney test for severity. For blood analysis, results are givethe course of the experiment (Figure 7C). Given that
DTx only eliminates existing Tregs while not preventing
new Treg generation, the selective pressure to maintain
Tregs, and the low dose of DTx used, it was not surpris-
ing to find that circulating Tregs were not lost. Consist-
ent with our previous findings using βgal as a target
neo-self Ag, these results suggest that Tregs need to be
present within the retina to have a protective effect.
Discussion
Previously we demonstrated that antigen-specific pTregs
could be generated in an ‘on-demand’ manner within
the retina and be protective against experimentally in-
duced autoimmunity directed against the neo-self anti-
gen βgal [26], suggesting that pTregs are an important
mechanism for homeostasis of immune privileged tissue.
In this study we further assessed the nature of retinal
pTregs and showed they are protective against auto-
immune disease directed at the endogenous retinal anti-
gen IRBP and also protective against spontaneous retinal
autoimmunity. We also assessed the role of retinal APC,
providing evidence that it is the local DC, and not MG,
within the retina that are crucial for generating both Teff
and Treg responses to retinal Ags.
Using βgal-specific CD4+ TCR Tg (BG2) mice in this
study along with βgal-specific CD8+ TCR Tg (BG1) miceautoimmune disease is enhanced in retinas depleted of
immune uveoretinitis (EAU) in IRBP-immunized only FDG mice and in
theria toxin (DTx) into the right anterior chamber of the eye (AC). Mice
munization. Retinas were analyzed for EAU at 21 days post-immunization.
the right AC. (C) Analysis of blood for Tregs in naïve (day 0) and
ven, P values were determined by Fisher’s exact test for incidence
n as mean ± SD with P value determined by t test.
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sponse to βgal could be modulated by the addition or
subtraction of FoxP3+ Tregs. Although βgal expression
was absent in these TCR Tg mice, the ability to up or
down regulate the DTH response by altering Treg levels
implies a certain baseline amount of tTreg-mediated
control in naïve TCR Tg mice. It has been demonstrated
that T cells specific for foreign or neo-self Ags can be
positively selected in the thymus via cross-reactive
(Ag-mimicking) self-peptides [61,62]. This accounts for
the Ag-specific T cell response in wild-type mice follow-
ing βgal immunization and allows for the formal possibil-
ity that naïve mice have a limited number of βgal-reactive
tTregs, especially BG2 mice given their large number of
Ag-specific precursor T cells. Nonetheless, experiments
herein using Rag−/− mice transferred with FoxP3− precur-
sor T cells clearly demonstrated the Ag-dependent periph-
eral generation of βgal-specific Tregs. Combined with our
previous results [26], we propose that locally generated, lo-
cally acting, Ag-specific pTregs are a crucial factor in the
contribution of Tregs towards retinal immune privilege
and that tTregs to βgal generated by selection on cross-
reactive self-peptides are limited in number and function.
Underscoring the importance of local Tregs in retinal
immune privilege is the observation that local Treg de-
pletion from the retina enhanced IRBP-induced EAU,
recapitulating the results found with retinal βgal [26]. In
addition to being highly expressed in the retina, there is
also aire promoted expression of IRBP in the thymus
[63,64] providing a certain level of tolerance to IRBP-
mediated autoimmunity mediated by negative selection
and generation of Ag-specific tTregs. While these studies
clearly demonstrated the importance of central tolerance
to IRBP in mitigating autoimmunity, there are circum-
stances that suggest that locally generated IRBP-specific
pTregs also contribute to retinal immune privilege. First,
based on the amount of IRBP in the human retina [65]
and the relative size of the human and murine retina
[66-68], we estimate endogenous IRBP in the retina to be
at least tenfold the concentration of retinal βgal in the βgal
mice. This high level of IRBP expression in an environ-
ment that is primed by high concentrations of TGF-β and
retinoic acid for Treg production [69-72] makes IRBP-
specific pTreg generation likely. Second, an IRBP-specific
Teff population that escaped negative selection has been
described [73] and thus making obvious a need for periph-
eral regulation. While it has been shown that this T cell
population has limited pathogenicity [73,74], the ability to
regulate its priming and effector functions within the
retina would be an efficient method of control. Unlike
our previous studies with βgal, we did not formally
demonstrate herein that IRBP-specific pTregs are
made in the retina. However, our results combined
with other investigations suggest that it is likely, if notnecessary, that there be local production of IRBP-
specific pTregs.
Our retinal βgal/BG2 TCR Tg/FoxP3-DTR model sys-
tem is well suited for demonstrating the role of pTregs
in tissue-specific immune privilege in that naive mice,
whether expressing one or any combination of the trans-
genes, do not develop autoimmune disease. This is in
contrast to other models of autoimmune disease, includ-
ing EAU, using TCR Tg mice specific for self-Ag or
neo-self Tg Ag that actually develop a high level of spon-
taneous autoimmune disease [75-77] despite thymic ex-
pression of the Ag. In these models, autoimmunity
induced by Treg depletion might not be distinguishable
from the spontaneous autoimmunity. Since we had dem-
onstrated that retinal depletion of Tregs enhanced EAU
in βgal-FDG mice that were either βgal-immunized or
transferred with activated βgal-specific T cells [26] it was
logical to ascertain whether the same depletion regimen
could induce autoimmunity in otherwise naive βgal-
FDG-BG2 mice. Our finding that significant EAU was
only found in DTx-treated eyes of the triple Tg mice and
not in their contralateral eye nor in mice lacking one or
more of the transgenes further supports the idea that
local action of Ag-specific Tregs is a crucial component
of retinal immune privilege.
An interesting difference between immunized/trans-
ferred βgal-FDG mice of our previous study [26] and
βgal-FDG-BG2 mice herein was that significant systemic
Treg depletion induced by high doses of DTx caused
EAU only in βgal-FDG-BG2 mice and then only at a rate
equal to that observed with local depletion. In rodent
strains with limited susceptibility for EAU [57], the high-
est incidence and severity of disease is associated with
situations that involve a chronic stimulation of a large T
cell population such as lymphopenia [44], activation by
commensal microbiota [76,78,79], antigen mimicry [80],
and Treg loss or lack of production [64,81]. Given the
high frequency of βgal-specific T cells in βgal-FDG-BG2
mice, it is likely that the lympho-proliferation associated
with systemic Treg depletion [4] resulted in a significant
T cell activation that was sufficient to overcome the on-
going, local production of pTregs in the retina. Although
higher doses of DTx or longer treatment would be lethal
to βgal-FDG-BG2 mice, we speculate that it would result
in higher incidence and severity of EAU. Nonetheless,
the results herein and previously [26] suggest that it is the
local Tregs within the retina, and their on-going gener-
ation, that sets the threshold for retinal autoimmune
disease.
Our retinal βgal/BG2 TCR Tg/FoxP3-DTR model sys-
tem is also useful in examining the initial, critical com-
ponent of local immune regulation - namely the effect of
Ag expression within the tissue on the immune re-
sponse. Meaningful comparison of retinal T cells from
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cult due to their intrinsically low numbers within the
retina. However, a direct and local antigenic challenge of
BG2 mice revealed that those also expressing retinal βgal
were highly resistant to generating a T cell response,
even in mice whose Tregs were pre-depleted by systemic
injection of DTx. This finding is consistent with our pre-
vious observation that DC from naïve retina favor Treg
production. DC within βgal expressing naïve retina gen-
erate βgal-specific Tregs, which in turn create and main-
tain an immunologically quiescent local environment.
Alternatively, or in conjunction with enhanced Treg
production, expression of βgal within the retina could
induce T cell anergy. This would most likely occur in
quiescent retinas that have few DC. This allows other
cells with APC ability, such as MG, to present self-Ag.
However, retinal APC other than DC may lack the
proper co-stimulatory molecules to activate T cells, a situ-
ation well understood to generate T cell anergy [82,83].
Regardless of the mechanisms, the tenacity of this immuno-
logical unresponsiveness is evidenced by our observations
herein and previously [26] that unilateral treatment gener-
ating a high rate of EAU in ipsilateral eyes of βgal-FDG
mice and βgal-FDG-BG2 mice fails to generate disease
within contralateral eyes.
While the presence of DC and their function as APC
within the retina is still a matter of active investigation,
recent in vitro studies have provided evidence that direct
contact between DC and T cells is necessary for retinal
T cell responses. In addition to our report showing Teff
and Treg generation mediated by purified retinal DC
[39], it has also been demonstrated that CD4+ T cells
specific for an ocular transgene required DC plus Ag to
become pathogenic [84]. Further, we also demonstrated
in a model of EAU mediated by CD8+ T cells, in con-
junction with MHC class I−/− mice, that pathogenicity
requires only the resident retinal cells be MHC class I+
[60], again suggesting local but not recruited APC are
crucial for retinal T cell responses. Use of a mouse com-
bining the FG transgene, which identifies Tregs but lacks
DTR, with the transgenes of the CDG and BG2 mice
allowed us to exam directly in vivo if retinal DC were
significant contributors to the APC function in retina.
Other retinal cells including endothelial cells [85,86],
retinal pigment epithelial cells [87,88], and especially
MG [28-33] have been proposed to have APC activity.
Although these putative retinal APC vastly outnumber
retinal DC and are not depleted by DTx treatment in
mice with the CDG transgene, we found that generation
of Teffs and Tregs within the retina as well as T cell me-
diated pathogenicity was completely dependent on DTR
+GFP+ retinal DC. While these other cell types have
been shown to modulate T cell responses and perhaps
have secondary APC function, their apparent lack offunction as APC in the absence of DC clearly demon-
strates that retinal DC are required for initiation of ret-
inal T cell responses.
Conclusions
In conclusion, we have demonstrated that the retinal en-
vironment is capable of Ag-specific pTreg generation
and that those pTregs act locally within the retina to
limiting both spontaneous and induced autoimmune dis-
ease. We have also demonstrated that the presence of
βgal within the retina limits the T cell response to chal-
lenge with exogenous βgal and that local DC within the
retina are critical for generating T cell responses within
the retina.
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